Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Learning Disabilities01:25

Learning Disabilities

652
Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
652
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

559
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
559
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

820
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
820
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

265
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
265
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

506
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
506

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protein Profile of Multiple Myeloma-Derived Extracellular Vesicles for the Discovery of Novel Myeloma-Related Biomarkers.

Cancer science·2026
Same author

Vertebrogenic Low Back Pain and Basivertebral Nerve Ablation: A Review of Mechanisms, Imaging-Driven Selection, and Clinical Outcomes.

Diagnostics (Basel, Switzerland)·2026
Same author

Nanoplastics perturb extracellular vesicle-mediated communication in the in vitro and ex vivo bone marrow microenvironment of multiple myeloma.

Journal of hazardous materials·2026
Same author

Microvascular flow imaging in musculoskeletal ultrasound: from technical innovation to clinical integration.

Journal of ultrasonography·2026
Same author

A Robust Methodological Framework for Generating Whole-Brain and Cortical Organoids From Diverse Healthy- and Patient-Derived Induced Pluripotent Stem Cell Lines.

Biology of the cell·2026
Same author

Missense Variants in Nutrition-Related Genes: A Computational Study.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Feb 22, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

8.6K

E-Learning for Rare Diseases: An Example Using Fabry Disease.

Chiara Cimmaruta1, Ludovica Liguori2,3, Maria Monticelli4

  • 1Dipartimento di Biologia, Università Federico II, 80126 Napoli, Italy. chiara.cimmaruta@unina.it.

International Journal of Molecular Sciences
|September 27, 2017
PubMed
Summary

This tutorial demonstrates a cost-effective bioinformatics method for diagnosing rare genetic disorders like Fabry disease using DNA sequencing. It aids in identifying mutations and exploring potential therapeutic options.

Keywords:
bioinformatics educationbioinformatics toolslaboratory guidepharmacological chaperonerare disease

More Related Videos

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

7.1K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

21.4K

Related Experiment Videos

Last Updated: Feb 22, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

8.6K
The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

7.1K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

21.4K

Area of Science:

  • Genetics
  • Bioinformatics
  • Molecular Biology

Background:

  • Rare diseases pose diagnostic challenges due to infrequent patient encounters and overlapping symptoms with common conditions.
  • Genetic confirmation through DNA sequencing is crucial for accurate rare disease diagnosis.
  • Fabry disease serves as a model for illustrating molecular analysis techniques.

Purpose of the Study:

  • To provide a tutorial on the molecular analysis of rare diseases, using Fabry disease as an example.
  • To introduce an accessible bioinformatics approach for diagnosing genetic disorders.
  • To familiarize readers with therapeutic strategies for specific genetic mutations.

Main Methods:

  • Exonic sequence analysis against human reference data using a genome browser.
  • Identification of missense mutations via BlastX.
  • Assessment of mutation pathogenicity using PolyPhen-2 and disease-specific databases.
  • Retrieval of protein information from UniProt.

Main Results:

  • An inexpensive bioinformatics workflow for Fabry disease diagnosis was developed.
  • The approach facilitates understanding of mutation impact and potential therapeutic interventions.
  • Introduction to pharmacological chaperones as a genotype-specific treatment for Fabry disease.

Conclusions:

  • Exome sequencing analysis principles can be simplified using web tools and databases.
  • This approach aids in both diagnosis and therapeutic decision-making for rare genetic diseases.
  • Web-based resources facilitate the understanding and application of genetic analysis in clinical settings.